Cargando…

Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression

OBJECTIVE: Roux-en-Y gastric bypass surgery (RYGB) improves the first phase of glucose-stimulated insulin secretion (GSIS) in patients with type 2 diabetes. How it does so remains unclear. Farnesoid X receptor (FXR), the nuclear receptor of bile acids (BAs), is implicated in bariatric surgery. Moreo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Xiangchen, Tu, Yifan, Li, Bingfeng, Zhang, Longmei, Feng, Linxian, Wang, Lixiang, Zhang, Lin, Zhou, Huarong, Hua, Xianxin, Ma, Xiaosong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728758/
https://www.ncbi.nlm.nih.gov/pubmed/31668381
http://dx.doi.org/10.1016/j.molmet.2019.08.009
_version_ 1783449475202678784
author Kong, Xiangchen
Tu, Yifan
Li, Bingfeng
Zhang, Longmei
Feng, Linxian
Wang, Lixiang
Zhang, Lin
Zhou, Huarong
Hua, Xianxin
Ma, Xiaosong
author_facet Kong, Xiangchen
Tu, Yifan
Li, Bingfeng
Zhang, Longmei
Feng, Linxian
Wang, Lixiang
Zhang, Lin
Zhou, Huarong
Hua, Xianxin
Ma, Xiaosong
author_sort Kong, Xiangchen
collection PubMed
description OBJECTIVE: Roux-en-Y gastric bypass surgery (RYGB) improves the first phase of glucose-stimulated insulin secretion (GSIS) in patients with type 2 diabetes. How it does so remains unclear. Farnesoid X receptor (FXR), the nuclear receptor of bile acids (BAs), is implicated in bariatric surgery. Moreover, the transient receptor potential ankyrin 1 (TRPA1) channel is expressed in pancreatic β-cells and involved in insulin secretion. We aimed to explore the role of BAs/FXR and TRPA1 in improved GSIS in diabetic rats after RYGB. METHODS: RYGB or sham surgery was conducted in spontaneous diabetic Goto-Kakizaki (GK) rats, or FXR or TRPA1 transgenic mice. Gene and protein expression of islets were assessed by qPCR and western blotting. Electrophysiological properties of single β-cells were studied using patch-clamp technique. Binding of FXR and histone acetyltransferase steroid receptor coactivator-1 (SRC1) to the TRPA1 promoter, acetylated histone H3 (ACH3) levels at the TRPA1 promoter were determined using ChIP assays. GSIS was measured using enzyme-linked immunosorbent assays or intravenous glucose tolerance test (IVGTT). RESULTS: RYGB increases GSIS, particularly the first-phase of GSIS in both intact islets and GK rats in vivo, and ameliorates hyperglycemia of GK rats. Importantly, the effects of RYGB were attenuated in TRPA1-deficient mice. Moreover, GK β-cells displayed significantly decreased TRPA1 expression and current. Patch-clamp recording revealed that TRPA1(−/−) β-cells displayed a marked hyperpolarization and decreased glucose-evoked action potential firing, which was associated with impaired GSIS. RYGB restored TRPA1 expression and current in GK β-cells. This was accompanied by improved glucose-evoked electrical activity and insulin secretion. Additionally, RYGB-induced TRPA1 expression involved BAs/FXR-mediated recruitment of SRC1, promoting ACH3 at the promoter of TRPA1. CONCLUSIONS: The BAs/FXR/SRC1 axis-mediated restoration of TRPA1 expression plays a critical role in the enhanced GSIS and remission of diabetes in GK rats after RYGB.
format Online
Article
Text
id pubmed-6728758
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-67287582019-09-12 Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression Kong, Xiangchen Tu, Yifan Li, Bingfeng Zhang, Longmei Feng, Linxian Wang, Lixiang Zhang, Lin Zhou, Huarong Hua, Xianxin Ma, Xiaosong Mol Metab Original Article OBJECTIVE: Roux-en-Y gastric bypass surgery (RYGB) improves the first phase of glucose-stimulated insulin secretion (GSIS) in patients with type 2 diabetes. How it does so remains unclear. Farnesoid X receptor (FXR), the nuclear receptor of bile acids (BAs), is implicated in bariatric surgery. Moreover, the transient receptor potential ankyrin 1 (TRPA1) channel is expressed in pancreatic β-cells and involved in insulin secretion. We aimed to explore the role of BAs/FXR and TRPA1 in improved GSIS in diabetic rats after RYGB. METHODS: RYGB or sham surgery was conducted in spontaneous diabetic Goto-Kakizaki (GK) rats, or FXR or TRPA1 transgenic mice. Gene and protein expression of islets were assessed by qPCR and western blotting. Electrophysiological properties of single β-cells were studied using patch-clamp technique. Binding of FXR and histone acetyltransferase steroid receptor coactivator-1 (SRC1) to the TRPA1 promoter, acetylated histone H3 (ACH3) levels at the TRPA1 promoter were determined using ChIP assays. GSIS was measured using enzyme-linked immunosorbent assays or intravenous glucose tolerance test (IVGTT). RESULTS: RYGB increases GSIS, particularly the first-phase of GSIS in both intact islets and GK rats in vivo, and ameliorates hyperglycemia of GK rats. Importantly, the effects of RYGB were attenuated in TRPA1-deficient mice. Moreover, GK β-cells displayed significantly decreased TRPA1 expression and current. Patch-clamp recording revealed that TRPA1(−/−) β-cells displayed a marked hyperpolarization and decreased glucose-evoked action potential firing, which was associated with impaired GSIS. RYGB restored TRPA1 expression and current in GK β-cells. This was accompanied by improved glucose-evoked electrical activity and insulin secretion. Additionally, RYGB-induced TRPA1 expression involved BAs/FXR-mediated recruitment of SRC1, promoting ACH3 at the promoter of TRPA1. CONCLUSIONS: The BAs/FXR/SRC1 axis-mediated restoration of TRPA1 expression plays a critical role in the enhanced GSIS and remission of diabetes in GK rats after RYGB. Elsevier 2019-08-15 /pmc/articles/PMC6728758/ /pubmed/31668381 http://dx.doi.org/10.1016/j.molmet.2019.08.009 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Kong, Xiangchen
Tu, Yifan
Li, Bingfeng
Zhang, Longmei
Feng, Linxian
Wang, Lixiang
Zhang, Lin
Zhou, Huarong
Hua, Xianxin
Ma, Xiaosong
Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression
title Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression
title_full Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression
title_fullStr Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression
title_full_unstemmed Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression
title_short Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression
title_sort roux-en-y gastric bypass enhances insulin secretion in type 2 diabetes via fxr-mediated trpa1 expression
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728758/
https://www.ncbi.nlm.nih.gov/pubmed/31668381
http://dx.doi.org/10.1016/j.molmet.2019.08.009
work_keys_str_mv AT kongxiangchen rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression
AT tuyifan rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression
AT libingfeng rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression
AT zhanglongmei rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression
AT fenglinxian rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression
AT wanglixiang rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression
AT zhanglin rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression
AT zhouhuarong rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression
AT huaxianxin rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression
AT maxiaosong rouxenygastricbypassenhancesinsulinsecretionintype2diabetesviafxrmediatedtrpa1expression